Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Recruiting Status: Active, not recruiting Age: 18 – 65 Years Old A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study in Healthy Volunteers and a Phase 2a, Open-Label Study in Patients with Hereditary Angioedema to Evaluate the Safety, Tolerability, PK and PD of ADX-324. Learn More

The release as fetched from its publisher. adarx.com ↗